• Skip to primary navigation
  • Skip to main content
  • Skip to footer

HepVu

HepVu

An estimated 3.5 million people in the U.S. are living with chronic Hepatitis C infection.

  • View the Map
  • Local Data
  • Find Services
  • News & Updates
  • Events
  • Tools & Resources
Home News & Updates Viral Hepatitis National Strategic Plan: A Roadmap to Elimination 2021-2025

Viral Hepatitis National Strategic Plan: A Roadmap to Elimination 2021-2025

January 12, 2021

According to the U.S. Department of Health and Human Services (HHS), there are an estimated 2.4 million people living with Hepatitis C, approximately 850,000 to 2.2 million people living with Hepatitis B, and more than 30 states have been affected by Hepatitis A outbreaks in the United States.

In 2016, the World Health Organization (WHO) established two goals to accomplish by 2030: reduce new viral hepatitis infections by 90% and hepatitis-related deaths by 65%. In pursuit of these goals, the U.S. has published multiple national strategic plans to address the domestic viral hepatitis epidemic.

Share Facebook Twitter Pinterest LinkedIn

The latest plan released by the U.S. Department of Health and Human Services (HHS), Viral Hepatitis National Strategic Plan: A Roadmap to Elimination 2021-2025, encourages collaboration across private and public stakeholders at all levels to achieve viral hepatitis elimination. The plan encompasses strategies towards eliminating the following three viruses: Hepatitis A, B, and C.

This plan establishes five main goals:

  • Prevent new viral hepatitis infections
  • Improve viral hepatitis-related health outcomes of people with viral hepatitis
  • Reduce viral hepatitis-related disparities and health inequities
  • Improve viral hepatitis surveillance and data usage
  • Achieve integrated, coordinated efforts that address the viral hepatitis epidemics among partners and stakeholders

In addition, the plan establishes core indicators to monitor progress in each specific hepatitis virus and among at-risk populations to achieve viral hepatitis elimination.

The Viral Hepatitis National Strategic Plan also identifies “priority populations” to ensure that viral hepatitis elimination efforts reach communities disproportionately impacted by viral hepatitis. The priority populations include Asians and Pacific Islanders, American Native/Alaskan Indians, non-Hispanic Blacks, people who inject drugs, people living with HIV, people experiencing homelessness, and people born between 1945 to 1965.

Addressing a multitude of public health challenges, the plan recognizes the necessity of a “syndemic approach” to address viral hepatitis, HIV, STIs, and substance use disorders, and was “developed concurrently and in alignment with the inaugural STI National Strategic Plan and the next iteration of the HIV National Strategic Plan.”

The plan aims to maximize elimination efforts and utilize resources from networks at all levels. Amidst the global pandemic, the plan brings back necessary attention towards ending the viral hepatitis crisis across the country.

To learn more about the efforts to eliminate viral hepatitis, explore HepVu’s Deeper Look on Viral Hepatitis Elimination.

Visualize the Viral Hepatitis Epidemic

  • Visualize state-level Hepatitis C and opioid epidemic data on HepVu’s interactive map.
  • View state-level Hepatitis C statistics, downloadable charts, and local resources on HepVu’s local data profiles.

Learn From Experts

January 7, 2021

Dr. Carolyn Wester on CDC’s Division of Viral Hepatitis 2025 Strategic Plan

Read More

July 28, 2020

Dr. Su Wang on the State of Global Hepatitis Elimination During COVID-19

Read More

May 18, 2020

Vu Q&A: Lauren Canary on Hepatitis Surveillance During COVID-19

Read More

Most Read

A Year in Review: HepVu’s 2019 Highlights
Addressing Increases in Hepatitis C Infections Linked to the Opioid Epidemic
Share Facebook Twitter LinkedIn Email

Keep Reading

May 4, 2017

Hepatitis B Infographics

Read More

May 18, 2018

Hepatitis Testing Day

Read More

Sign up for HepVu updates.

Footer

AIDSVu HepVu

HepVu is presented by Emory University’s Rollins School of Public Health in partnership with Gilead Sciences, Inc.

  • About
  • FAQ
  • Data Methods
  • Datasets

Questions?
Info@HepVu.org

Media Inquiries
(202) 854-0480
Media@HepVu.org

Follow Us

  • Facebook
  • Twitter

© 2023 HepVu. All Rights Reserved.

  • Privacy Policy
  • Contact Us

Get HepVu in Your Inbox

Sign up to stay informed on new data, maps, expert Q&As, and infographics about Hepatitis C and opioids where you live.